Overview

Buprenorphine Detoxification - BBDVI - 19

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to examine the long-term efficacy of alternate-day dosing schedules in promoting treatment compliance in the absence of confounding behavioral contingencies.

Phase:

Phase 2

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Collaborator:

University of Vermont

Treatments:

Buprenorphine